Go Pro
NASDAQ:ABP

Abpro Q2 2025 Earnings Report

Abpro logo
$0.52 0.00 (0.00%)
As of 07/17/2026

Abpro EPS Results

Actual EPS
-$1.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Abpro Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Abpro Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Abpro Earnings Headlines

Abpro Holdings Faces Nasdaq Delisting, Moves to OTC
Abpro Holdings Directors Resign, Board Seeks Replacements
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. Elon believes what Michael Robinson calls 'Project Unlimited' could unlock $100 trillion in potential growth. One little-known company sits at the center of it all, and most investors have no idea it exists. Position yourself before this company potentially hits the front page.tc pixel
ABPO Abpro Holdings, Inc.
Abpro Bio Co. Ltd.
See More Abpro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Abpro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abpro and other key companies, straight to your email.

About Abpro

Abpro (NASDAQ:ABP) is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

View Abpro Profile